| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.5M | +492.0% |
| Cost of Revenue | $2.1M | +1047.9% |
| Gross Profit | $1.4M | +242.4% |
| R&D Expense | $6.8M | +256.4% |
| SG&A Expense | $8.5M | +262.1% |
| Operating Income | -$14.0M | -261.4% |
| Interest Expense | $54K | +146.4% |
| Income Tax | $0 | — |
| Net Income | -$14.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | +5.8% |
| Accounts Receivable | $202K | — |
| Inventory | $595K | +224.5% |
| Current Assets | $2.8M | +28.3% |
| Total Assets | $37.1M | -9.1% |
| Current Liabilities | $2.5M | -91.9% |
| Total Liabilities | $2.5M | -91.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -141.7% |
| Capital Expenditures | $634K | +340.8% |
| Investing Cash Flow | -$630K | -249.1% |
| Financing Cash Flow | $3.8M | +21.5% |
| Free Cash Flow | -$3.7M | -162.2% |
| -260.2% |
| Stockholders' Equity |
| $34.6M |
| +239.6% |